Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, launches new Contract Development and Manufacturing Organization (CDMO) focused on sterile injectable drug products. This follows the recent announcement on the acquisition of the Perth sterile injectable manufacturing plant from Pfizer.
The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Manufacturing Organization (CDMO) under the name NovaCina
